Somayeh Aslani

456 total citations
15 papers, 360 citations indexed

About

Somayeh Aslani is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Somayeh Aslani has authored 15 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Clinical Biochemistry. Recurrent topics in Somayeh Aslani's work include Mesenchymal stem cell research (5 papers), Advanced Glycation End Products research (4 papers) and MicroRNA in disease regulation (4 papers). Somayeh Aslani is often cited by papers focused on Mesenchymal stem cell research (5 papers), Advanced Glycation End Products research (4 papers) and MicroRNA in disease regulation (4 papers). Somayeh Aslani collaborates with scholars based in Iran, Türkiye and United States. Somayeh Aslani's co-authors include Davoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, Alireza Abhari, Leila Roshangar, Saeed Nazari Soltan Ahmad, Ebrahim Sakhinia, Jalil Rashedi, Reza Rahbarghazi‬ and Mehran Mesgari Abbasi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Somayeh Aslani

14 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Somayeh Aslani Iran	7	128	116	85	74	37	15	360
Yicheng Jiang China	7	88 0.7×	129 1.1×	61 0.7×	35 0.5×	28 0.8×	15	318
Aowen Zhuang Australia	9	92 0.7×	114 1.0×	149 1.8×	91 1.2×	13 0.4×	18	383
Anni Song China	9	34 0.3×	142 1.2×	40 0.5×	119 1.6×	34 0.9×	16	424
Qianwei Cui China	11	48 0.4×	90 0.8×	29 0.3×	29 0.4×	24 0.6×	25	342
Biao Xu China	11	49 0.4×	201 1.7×	50 0.6×	22 0.3×	39 1.1×	17	445
Yoko Oyama Japan	8	70 0.5×	109 0.9×	29 0.3×	21 0.3×	21 0.6×	20	330
Shuang Chu China	10	36 0.3×	148 1.3×	63 0.7×	83 1.1×	25 0.7×	12	434
Xu-shun Jiang China	10	36 0.3×	147 1.3×	38 0.4×	86 1.2×	27 0.7×	15	350
Rodrigo Tallada Iborra Brazil	12	122 1.0×	65 0.6×	132 1.6×	18 0.2×	24 0.6×	21	347

Countries citing papers authored by Somayeh Aslani

Since Specialization

Citations

This map shows the geographic impact of Somayeh Aslani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Somayeh Aslani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Somayeh Aslani more than expected).

Fields of papers citing papers by Somayeh Aslani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Somayeh Aslani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Somayeh Aslani. The network helps show where Somayeh Aslani may publish in the future.

Co-authorship network of co-authors of Somayeh Aslani

This figure shows the co-authorship network connecting the top 25 collaborators of Somayeh Aslani. A scholar is included among the top collaborators of Somayeh Aslani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Somayeh Aslani. Somayeh Aslani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Aslani, Somayeh, et al.. (2026). Integrated bioinformatics and tissue-based validation reveal the oncogenic role of hsa_circ_0043256 and hsa_circ_0004789 in gastric cancer. Biochemistry and Biophysics Reports. 45. 102442–102442.

Kalantary‐Charvadeh, Ashkan, et al.. (2024). The role of long non-coding RNA LINC00839 in oral squamous cell carcinoma based on bioinformatics and experimental research. Scientific Reports. 14(1). 31817–31817. 3 indexed citations

Kalantary‐Charvadeh, Ashkan, et al.. (2023). β‐lapachone protects against doxorubicin‐induced hepatotoxicity through modulation of NAD⁺/SIRT‐1/FXR/p‐AMPK/NF‐kB and Nrf2 signaling axis. Journal of Biochemical and Molecular Toxicology. 38(1). e23564–e23564. 3 indexed citations

Ahmadi, Mahdi, et al.. (2021). Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes. Advanced Pharmaceutical Bulletin. 12(2). 237–247. 6 indexed citations

Aslani, Somayeh, et al.. (2021). Level of miR-101a and miR-107 in Human Adipose Mesenchymal Stem Cells Committed to Insulin-producing Cells.. PubMed. 10(1). 68–74. 4 indexed citations

Sanajou, Davoud, et al.. (2021). β-LAPachone is renoprotective in streptozotocin-induced diabetic mice via regulating the PI3K/Akt/mTOR signaling pathway.. SHILAP Revista de lepidopterología. 24(5). 650–656. 2 indexed citations

Aslani, Somayeh, et al.. (2020). Expression Profiles of MicroRNAs in Stem Cells Differentiation. Current Pharmaceutical Biotechnology. 21(10). 906–918. 4 indexed citations

Aslani, Somayeh, et al.. (2020). Dynamic of miRNA-101a-3p and miRNA-200a during Induction of Osteoblast Differentiation in Adipose-derived Mesenchymal Stem Cells.. PubMed Central. 9(2). 140–146. 3 indexed citations

Rahbarghazi‬, Reza, Somayeh Aslani, Zeinab Latifi, et al.. (2019). Promoter methylation and expression pattern of DLX3, ATF4, and FRA1 genes during osteoblastic differentiation of adipose-derived mesenchymal stem cells. Bioimpacts. 10(4). 243–250. 5 indexed citations

10.

Hosseini, Vahid, et al.. (2019). Current Status of Used Protocols for Mesenchymal Stem Cell Differentiation: A Focus on Insulin Producing, Osteoblast-Like and Neural Cells. Current Stem Cell Research & Therapy. 14(7). 570–578. 10 indexed citations

11.

Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, et al.. (2018). Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat. European Journal of Pharmacology. 842. 40–48. 24 indexed citations

12.

Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, et al.. (2018). FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats. Journal of Physiology and Biochemistry. 74(3). 467–478. 25 indexed citations

13.

Sanajou, Davoud, Amir Ghorbani Haghjo, Hassan Argani, & Somayeh Aslani. (2018). AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. European Journal of Pharmacology. 833. 158–164. 237 indexed citations

14.

Aslani, Somayeh, et al.. (2018). Interplay between microRNAs and Wnt, transforming growth factor‐β, and bone morphogenic protein signaling pathways promote osteoblastic differentiation of mesenchymal stem cells. Journal of Cellular Physiology. 234(6). 8082–8093. 26 indexed citations

15.

Dehghani, Rouhullah, et al.. (2014). Case report of Stomoxys calcitrans bites in residential area of Kashan, Iran. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 23(110). 257–261. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact